Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armando Gabrielli

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Cells|January 2, 2020
Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?Devis Benfaremo, Armando Gabrielli
Nature Reviews. Rheumatology|May 8, 2021
Linking NAD metabolism and DNA repair to inflammation in SScEnrico Vittorio Avvedimento, Armando Gabrielli
Science Translational Medicine|April 9, 2010
Stiff and tight skin: a rear window into fibrosis without inflammationEnrico V Avvedimento, Armando Gabrielli
Internal and Emergency Medicine|March 13, 2021
Diagnosis and management of leukocytoclastic vasculitisPaolo Fraticelli, Devis Benfaremo, Armando Gabrielli
Journal of Immunology Research|July 6, 2019
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet NeedsDevis Benfaremo, Michele Maria Luchetti, Armando Gabrielli
The New England Journal of Medicine|May 8, 2009
SclerodermaArmando Gabrielli, Enrico V Avvedimento, Thomas Krieg
Current Drug Safety|October 15, 2015
Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety ProfileMichele Maria Luchetti, Andrea Balloni, Armando Gabrielli
Current Pharmaceutical Biotechnology|December 27, 2017
Biologics in Inflammatory and Immunomediated ArthritisMichele M Luchetti, Devis Benfaremo, Armando Gabrielli
Immunology Letters|October 17, 2017
Agonistic antibodies in systemic sclerosisGianluca Moroncini, Silvia Svegliati Baroni, Armando Gabrielli
BMJ Case Reports|October 10, 2019
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemiaPaolo Fraticelli, Devis Benfaremo, Marco Cardinali, et al.
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Cells|January 2, 2020
Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?Devis Benfaremo, Armando Gabrielli
Nature Reviews. Rheumatology|May 8, 2021
Linking NAD metabolism and DNA repair to inflammation in SScEnrico Vittorio Avvedimento, Armando Gabrielli
Science Translational Medicine|April 9, 2010
Stiff and tight skin: a rear window into fibrosis without inflammationEnrico V Avvedimento, Armando Gabrielli
Internal and Emergency Medicine|March 13, 2021
Diagnosis and management of leukocytoclastic vasculitisPaolo Fraticelli, Devis Benfaremo, Armando Gabrielli
Journal of Immunology Research|July 6, 2019
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet NeedsDevis Benfaremo, Michele Maria Luchetti, Armando Gabrielli
The New England Journal of Medicine|May 8, 2009
SclerodermaArmando Gabrielli, Enrico V Avvedimento, Thomas Krieg
Current Drug Safety|October 15, 2015
Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety ProfileMichele Maria Luchetti, Andrea Balloni, Armando Gabrielli
Current Pharmaceutical Biotechnology|December 27, 2017
Biologics in Inflammatory and Immunomediated ArthritisMichele M Luchetti, Devis Benfaremo, Armando Gabrielli
Immunology Letters|October 17, 2017
Agonistic antibodies in systemic sclerosisGianluca Moroncini, Silvia Svegliati Baroni, Armando Gabrielli
BMJ Case Reports|October 10, 2019
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemiaPaolo Fraticelli, Devis Benfaremo, Marco Cardinali, et al.
Pageof 20